CRISPR interference of essential stage-specific gene function in Chlamydia trachomatis
CRISPR interference of essential stage-specific gene function in Chlamydia trachomatis
批准号:
10644789
负责人:
LI SHEN
金额:
$23.98万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-17 至 2025-07-31
关键词:
AblationAddressBacteriaBacterial GenomeBacterial Sexually Transmitted DiseasesBiologyBlindnessCRISPR interferenceCellsCervicalCharacteristicsChlamydiaChlamydia InfectionsChlamydia trachomatisClinicalClustered Regularly Interspaced Short Palindromic RepeatsCodeCollaborationsComplementConsumptionCuesDNA-Directed RNA PolymeraseDataDevelopmentDevelopmental GeneDevelopmental ProcessDiseaseEnsureEpithelial CellsEssential GenesEventFemale infertilityFlow CytometryGene DeletionGene ExpressionGene Expression RegulationGene SilencingGene TargetingGenerationsGenesGeneticGenetic TranscriptionGlucoseGuide RNAHealthHumanIndividualInfectionInvadedInvestigationKnowledgeMediatingMethodsMicroscopyMolecularMorphologyOrganismOrthologous GenePathogenesisPelvic Inflammatory DiseasePlasmidsProcessProtocols documentationRNARegulationRegulatory PathwayReporterResearch PersonnelResearch Project GrantsSexual TransmissionStarvationTechnologyTestingTimeTrachomaTryptophanUnited StatesVariantWorkexperienceflexibilityfunctional groupgene functiongene productgene repressiongenetic analysisgenetic manipulationgenome-wide analysisinducible gene expressioninnovationinsightinterestknock-downmolecular phenotypenext generationpathogenic bacteriapromotersuccesstooltraittubal infertilityvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CRISPR interference of essential stage-specific gene function in Chlamydia
trachomatis
Abstract
Chlamydia trachomatis is a clinically important obligate intracellular bacterial pathogen and the
leading cause of preventable infectious blindness (trachoma) and bacterial sexually transmitted
diseases worldwide. If not cleared, then chlamydial infections can lead to poor health
consequences, such as pelvic inflammatory disease and tubal factor infertility in women. Despite
its devastating impacts on human health, much of C. trachomatis pathobiology remains unknown.
Whereas the characteristics of the developmental cycle of C. trachomatis are well studied, the
regulatory pathways and mechanisms remain poorly defined, undermining fundamental
understanding of C. trachomatis pathogenesis. It is extremely challenging to study essential
genes, whose disruption leads to lethality. To address this gap, we have successfully adapted
CRISPR interference (CRISPRi) gene silencing technology, which relies on inducible expression
of catalytically inactive variants of dCas orthologs that repress gene transcription at a specific
chromosomal locus in C. trachomatis. This approach allows for creation of conditional, reversible
knockdowns in individual genes that can also be complemented by including a plasmid-encoded
copy of the targeted gene as a transcriptional fusion with the dCas ortholog. Building on these
findings, we have further adapted our CRISPRi approaches to allow for multiplexed gene
knockdown for the targeted knockdown of multiple genes simultaneously. The objective of the
proposed study is to develop a next generation of CRISPR interference (CRISPRi) genetic editing
toolbox in C. trachomatis and to explore its utility towards elucidating the underlying mechanisms
of developmental gene regulation. In Specific Aim 1, we will establish an adaptable second
generation of CRISPRi platform, which enables tunable, trackable, and quantitative assessment
of CRISPRi-mediated changes in C. trachomatis cellular and molecular phenotypes in single cells.
In Specific Aim 2 we will test our hypothesis that a set of “known” and “unknown” genes are
essential for critical events of ending replication of reticulate bodies (RB) and RB differentiating
to the infectious elementary body (EB). Leveraging CRISPRi, this Aim will elucidate the relative
contributions of each essential gene product to C. trachomatis developmental processes critical
for EB formation and reinitiation of a new cycle of infection. Collectively, this innovative research
project will seek a focused investigation to illustrate what chlamydial factors are crucial for, and
how these factors directly contribute to, regulation of the late developmental cycle of C.
trachomatis. It is also significant, as the methods developed will be the starting point towards
interrogation of genome-wide studies of gene function and genetic interactions in C. trachomatis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Technology Identification and Training Core
-
批准号:10685539
-
项目类别:
-
资助金额:$15.37万
-
财政年份:2021
-
负责人:LI SHEN
-
依托单位:
Technology Identification and Training Core
-
批准号:10274450
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2021
-
负责人:LI SHEN
-
依托单位:
Technology Identification and Training Core
-
批准号:10491776
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2021
-
负责人:LI SHEN
-
依托单位:
Probing mechanism and outcome of Chlamydia trachomatis response to antimicrobial insults
-
批准号:9808730
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2019
-
负责人:LI SHEN
-
依托单位:
Integrative Bioinformatics Approaches to Human Brain Genomics and Connectomics
-
批准号:9482419
-
项目类别:
-
资助金额:$45.58万
-
财政年份:2016
-
负责人:LI SHEN
-
依托单位:
Integrative Bioinformatics Approaches to Human Brain Genomics and Connectomics
-
批准号:9324260
-
项目类别:
-
资助金额:$10.19万
-
财政年份:2016
-
负责人:LI SHEN
-
依托单位:
A molecular switch of the type III secretion system in Chlamydia trachomatis
-
批准号:8509139
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2012
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:8068066
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2010
-
负责人:LI SHEN
-
依托单位:
SPHARM Shape Modeling and Analysis Toolkit for Brain Imaging
-
批准号:7501075
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2008
-
负责人:LI SHEN
-
依托单位:
SPHARM Shape Modeling and Analysis Toolkit for Brain Imaging
-
批准号:7852070
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2008
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:7147432
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2004
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:7535548
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2004
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:6986724
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2004
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:7686508
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2004
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:6869401
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2004
-
负责人:LI SHEN
-
依托单位:
Analyses of sigma factor 28 of C. trachomatis
-
批准号:7338326
-
项目类别:
-
资助金额:$4.75万
-
财政年份:2004
-
负责人:LI SHEN
-
依托单位:
ID-Tag Protein Profiling Array for the Molecular Charact
-
批准号:6578495
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2003
-
负责人:LI SHEN
-
依托单位:
海外基金